First City Capital Management, Inc. reports 0.87% decrease in ownership of BRM / Bristol-Myers Squibb Company

Bristol-Myers Squibb Company

DE ˙ XTRA ˙ US1101221083

47,43 € ↓ -0,01 (-0,01%)

2026-06-04
DEL PRIS

Security	DE:BRM / Bristol-Myers Squibb Company
Institution	First City Capital Management, Inc.
Latest Disclosed Ownership	19,445 shares
Latest Disclosed Value	$ 1,179,339

On April 17, 2026 - First City Capital Management, Inc. filed a 13F-HR form disclosing ownership of 19,445 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $1,019,307 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 14, 2026 disclosing 19,615 shares of Bristol-Myers Squibb Company. This represents a change in shares of -0.87% during the quarter. The current value of the position is $922,276 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-04-17	2026-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	19,445	-170	-0.87	1,179	11.44	0.6251
2026-01-14	2025-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	19,615	-1,682	-7.90	1,058	10.21	0.5590
2025-10-21	2025-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	21,297	-425	-1.96	960	-4.48	0.5182
2025-07-15	2025-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	21,722	295	1.38	1,006	-23.05	0.5804
2025-04-11	2025-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	21,427	263	1.24	1,307	9.11	0.7836
2025-01-03	2024-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	21,164	219	1.05	1,197	10.53	0.6371
2024-11-07	2024-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	20,945	2,120	11.26	1,084	38.67	0.5574
2024-08-13	2024-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	18,825	-7,907	-29.58	782	-46.10	0.4392
2024-05-22	2024-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	26,732	1,171	4.58	1,450	10.53	0.8028
2024-02-07	2023-12-31	13F/A-1	BRISTOL-MYERS SQUIBB	COM	110122108	25,561	-614	-2.35	1,312	-13.69	0.7611
2024-02-07	2023-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	26,175	0		1,519		0.9538
2023-10-26	2023-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	26,175	-35	-0.13	1,519	-9.37	0.9538
2023-07-19	2023-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	26,210	-1,022	-3.75	1,676	-7.81	0.9894
2023-05-01	2023-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	27,232	-12	-0.04	1,818	-7.24	1.0632
2023-02-13	2022-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	27,244	-1,067	-3.77	1,960	-2.63	1.1805
2022-10-24	2022-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	28,311	-25	-0.09	2,013	-7.75	1.3272
2022-07-21	2022-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	28,336	-125	-0.44	2,182	4.95	1.3432
2022-05-04	2022-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	28,461	544	1.95	2,079	14.61	1.1454
2022-02-07	2021-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	27,917	-6,080	-17.88	1,814	-9.84	1.0202
2021-10-28	2021-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	33,997	-33	-0.10	2,012	-11.68	1.1325
2021-08-13	2021-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	34,030	-190	-0.56	2,278	3.17	1.2520
2021-05-13	2021-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	34,220	974	2.93	2,208	10.73	1.2789
2021-02-12	2020-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	33,246	-28,789	-46.41	1,994	-47.30	1.2751
2020-11-16	2020-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	62,035	29,073	88.20	3,784	95.25	1.4056
2020-08-14	2020-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	32,962	904	2.82	1,938	8.45	1.4878
2020-05-15	2020-03-31	13F	Bristol Myers Squibb	CS	110122108	32,058	-2,646	-7.62	1,787	-19.79	1.7509
2020-02-10	2019-12-31	13F	Bristol Myers Squibb	CS	110122108	34,704	-1,374	-3.81	2,228	21.75	1.5332
2019-11-13	2019-09-30	13F	Bristol Myers Squibb	CS	110122108	36,078	-1,353	-3.61	1,830	7.84	1.3384
2019-08-14	2019-06-30	13F	Bristol Myers Squibb	CS	110122108	37,431	-80	-0.21	1,697	-5.20	1.2363
2019-05-13	2019-03-31	13F	Bristol Myers Squibb	CS	110122108	37,511	-900	-2.34	1,790	-10.37	1.2867
2019-02-13	2018-12-31	13F	Bristol Myers Squibb	CS	110122108	38,411	-951	-2.42	1,997	-18.29	1.5567
2018-11-14	2018-09-30	13F	Bristol Myers Squibb	CS	110122108	39,362	-700	-1.75	2,444	10.24	1.6252
2018-08-13	2018-06-30	13F	Bristol Myers Squibb	CS	110122108	40,062	-145	-0.36	2,217	-12.82	1.5856
2018-05-15	2018-03-31	13F	Bristol Myers Squibb	CS	110122108	40,207	-370	-0.91	2,543	2.25	1.9026
2018-02-12	2017-12-31	13F	Bristol Myers Squibb	CS	110122108	40,577	-150	-0.37	2,487	-4.20	1.6961
2017-10-31	2017-09-30	13F	Bristol Myers Squibb	CS	110122108	40,727	-800	-1.93	2,596	12.19	1.8153
2017-08-14	2017-06-30	13F	Bristol Myers Squibb	CS	110122108	41,527	0	0.00	2,314	2.48	1.6784
2017-05-17	2017-03-31	13F/A-1	Bristol Myers Squibb	CS	110122108	41,527	-1,854	-4.27	2,258	-10.93	1.6633
2017-05-15	2017-03-31	13F	Bristol Myers Squibb	CS	110122108	44,034			3,239
2017-02-13	2016-12-31	13F	Bristol Myers Squibb	CS	110122108	43,381	7	0.02	2,535	8.43	1.9037
2016-11-10	2016-09-30	13F	Bristol Myers Squibb	CS	110122108	43,374	-660	-1.50	2,339	-27.82	1.7869
2016-08-15	2016-06-30	13F	Bristol Myers Squibb	CS	110122108	44,034	-174	-0.39	3,239	14.70	2.4505
2016-05-12	2016-03-31	13F	Bristol Myers Squibb	CS	110122108	44,208	-1,540	-3.37	2,824	-10.26	1.9320
2016-02-12	2015-12-31	13F	Bristol Myers Squibb	CS	110122108	45,748	-425	-0.92	3,147	15.15	2.1128
2015-11-16	2015-09-30	13F	Bristol Myers Squibb	CS	110122108	46,173	-2,101	-4.35	2,733	-14.91	2.0088
2015-08-17	2015-06-30	13F	Bristol Myers Squibb	CS	110122108	48,274	155	0.32	3,212	3.51	2.2320
2015-05-07	2015-03-31	13F	Bristol Myers Squibb	CS	110122108	48,119	-835	-1.71	3,104	7.41	2.1464
2015-02-13	2014-12-31	13F	Bristol Myers Squibb	CS	110122108	48,954	-1,007	-2.02	2,890	12.98	1.9937
2014-11-13	2014-09-30	13F	Bristol Myers Squibb	CS	110122108	49,961	-272	-0.54	2,557	4.97	1.8326
2014-08-18	2014-06-30	13F	Bristol Myers Squibb	CS	110122108	50,233	-672	-1.32	2,437	-7.87	1.7320
2014-05-19	2014-03-31	13F	Bristol Myers Squibb	CS	110122108	50,905	-597	-1.16	2,645	-3.40	1.8903
2014-02-14	2013-12-31	13F	Bristol Myers Squibb	CS	110122108	51,502	-4,086	-7.35	2,737	-99.89	2.2426
2013-12-06	2013-09-30	13F	Bristol Myers Squibb	COM	110122108	55,588	3,026	5.76	2,572,692	9.52	2.1275
2013-08-21	2013-06-30	13F	BRISTOL MYERS SQUIBB	COM	110122108	52,562	52,562		2,348,974		2.1440

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.